益生菌儿科临床应用循证指南(2023)  

Evidence-based guideline for pediatric clinical application of probiotics(2023)

作　　者：中华预防医学会微生态学分会 陈洁[2] 程茜 华子瑜 黄永坤 黄志华[5] 李小芹 李在玲[7] 舒赛男[5] 王宝西 王文建[9] 武庆斌[10] 张琳 郑跃杰[9] Society of Microecology,Chinese Preventive Medical Association;SHU Sai-nan;WANG Wen-jian

机构地区：[1]不详 [2]浙江大学医学院附属儿童医院 [3]重庆医科大学附属儿童医院 [4]昆明医科大学第一附属医院 [5]华中科技大学同济医学院附属同济医院 [6]河南省儿童医院 [7]北京大学第三医院 [8]空军军医大学唐都医院 [9]深圳市儿童医院 [10]苏州大学附属儿童医院 [11]河北医科大学第三医院

出　　处：《中国实用儿科杂志》2024年第1期1-15,20,共16页Chinese Journal of Practical Pediatrics

摘　　要：益生菌作为药物、食品或膳食补充剂用于儿科疾病防治的有效性和安全性已被广泛证实。近年来关于益生菌的研究数据不断更新。为了使医师更好地认识和使用益生菌,中华预防医学会微生态学分会儿科专家在2017年发布的《益生菌儿科临床应用循证指南》基础上,查询国内外新发表的文献并结合中国当前实际情况,制定指南,以期指导我国儿科临床规范应用益生菌。The efficacy and safety of probiotics as drugs,foods or dietary supplements for the prevention and treatment of pediatric diseases have been widely confirmed.In recent years,research on probiotics has been continuously updated.To help physicians better understand and use probiotics,pediatric experts from the Microecology Branch of the Chinese Society of Preventive Medicine have developed this guideline based on the"Evidence-Based Guideline for Pediatric Clinical Application of Probiotics"published in 2017,combined newly published literature from China and abroad,and considered the current actual situation in China,with a view to guiding the standard clinical application of probiotics in pediatrics in China.

关 键 词：益生菌 循证指南 儿童 

分 类 号：R72[医药卫生—儿科]